Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.74), $0.07 better than the analyst estimate of ($1.81). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $2.75 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.